Nektar Therapeutics Market Cap

Nektar Therapeutics has a market cap or net worth of $132.13 million as of May 14, 2025. Its market cap has decreased by -45.49% in one year.

Market Cap

132.13M

Enterprise Value

98.14M

1-Year Change

-45.49%

Ranking

#3881

Market Cap Chart

Since December 1, 1998, Nektar Therapeutics's market cap has decreased from $478.60M to $132.13M, a decrease of -72.39%. That is a compound annual growth rate of -4.75%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	133.10M	-22.39%
Dec 31, 2024	171.50M	59.09%
Dec 29, 2023	107.80M	-74.62%
Dec 30, 2022	424.80M	-82.96%
Dec 31, 2021	2.49B	-18.24%
Dec 31, 2020	3.05B	-19.69%
Dec 31, 2019	3.80B	-33.26%
Dec 31, 2018	5.69B	-39.50%
Dec 29, 2017	9.40B	401.47%
Dec 30, 2016	1.88B	-16.61%
Dec 31, 2015	2.25B	12.95%
Dec 31, 2014	1.99B	51.06%
Dec 31, 2013	1.32B	54.43%
Dec 31, 2012	853.40M	33.30%
Dec 30, 2011	640.20M	-47.19%
Dec 31, 2010	1.21B	39.56%
Dec 31, 2009	868.60M	68.99%
Dec 31, 2008	514.00M	-16.91%
Dec 31, 2007	618.60M	-54.96%
Dec 29, 2006	1.37B	-4.78%
Dec 30, 2005	1.44B	-15.13%
Dec 31, 2004	1.70B	122.51%
Dec 31, 2003	763.80M	70.57%
Dec 31, 2002	447.80M	-56.04%
Dec 31, 2001	1.02B	-55.42%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	659.45B
Johnson & Johnson	371.06B
UnitedHealth Group	345.29B
AbbVie	326.08B
Novo Nordisk	297.79B
Abbott Laboratories	231.82B
Novartis AG	214.71B
AstraZeneca	211.14B

Market Cap Rankings